Our latest research results just got published as article in Molecular Pharmaceutics!
Great work Denise, Dominika and Matthias, congrats!!   

The paper describes the surface modifications of sugar-based nanoparticles and the influence on immunostimmulatory effects. It is the first paper that shows that DEXylated particles can potentially be used for passive targeting of antigen presenting cells for future immunotherapeutic applications.

“Surface Modification of Polysaccharide-Based Nanoparticles with PEG and Dextran and the Effects on Immune Cell Binding and Stimulatory Characteristics”
Denise Bamberger, Dominika Hobernik, Matthias Konhäuser, Matthias Bros and Peter R. Wich
Mol. Pharmaceutics 2017, ASAP. (DOI: 10.1021/acs.molpharmaceut.7b00507)

 

Abstract:
Surface modifications of nanoparticles can alter their physical and biological properties significantly. They effect particle aggregation, circulation times, and cellular uptake. This is particularly critical for the interaction with primary immune cells due to their important role in particle processing. We can show that the introduction of a hydrophilic PEG layer on the surface of the polysaccharide-based nanoparticles prevents unwanted aggregation under physiological conditions and decreases unspecific cell uptake in different primary immune cell types. The opposite effect can be observed with a parallel-performed introduction of a layer of low molecular weight dextran (3.5 and 5 kDa) on the particle surface (DEXylation) that encourages the nanoparticle uptake by antigen-presenting cells like macrophages and dendritic cells. Binding of DEXylated particles to these immune cells results in an upregulation of surface maturation markers and elevated production of proinflammatory cytokines, reflecting cell activation. Hence, DEXylated particles can potentially be used for passive targeting of antigen presenting cells with inherent adjuvant function for future immunotherapeutic applications.

 

Surface Modification of Polysaccharide-Based Nanoparticles

 

 

0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

Top